Left ventricular anatomy and function in primary aldosteronism and renovascular hypertension

Area of Science:

• Cardiology
• Nephrology
• Endocrinology

Background:

• Left ventricular hypertrophy (LVH) is a significant complication of hypertension, increasing morbidity and mortality.
• The renin-angiotensin system (RAS) and aldosterone excess are implicated in LVH pathogenesis.
• Secondary hypertension models offer unique insights into human cardiac remodeling.

Purpose of the Study:

• To review cardiac changes in primary aldosteronism and renovascular hypertension.
• To elucidate the roles of RAS and aldosterone in the pathogenesis of LVH.
• To utilize 'exceptions' in hypertension to understand disease mechanisms.

Main Methods:

• Review of clinical data on LV changes in primary aldosteronism.
• Analysis of studies on LVH in renovascular hypertension.
• Comparative analysis of hypertensive subtypes to understand specific pathway contributions.

Main Results:

• Experimental data show angiotensin II induces myocardial hypertrophy.
• Aldosterone excess is linked to extracellular matrix deposition and myocardial fibrosis.
• Secondary hypertension models highlight distinct contributions of RAS and aldosterone to LVH.

Conclusions:

• The renin-angiotensin system and aldosterone play critical roles in the development of left ventricular hypertrophy.
• Studying rare secondary forms of hypertension provides valuable insights into LVH pathogenesis.
• Understanding these mechanisms is crucial for managing hypertensive heart disease.